AJANTPHARM — Ajanta Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Ajanta Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	33,410	37,426	42,087	46,481	54,529
Cost of Revenue
Gross Profit	24,543	26,259	30,934	35,210	42,691
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	25,331	30,620	31,561	35,196	42,312
Operating Profit	8,079	6,806	10,526	11,285	12,217
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	9,095	7,453	11,139	11,892	13,777
Provision for Income Taxes
Net Income After Taxes	7,127	5,880	8,162	9,204	10,560
Net Income Before Extraordinary Items
Net Income	7,127	5,880	8,162	9,204	10,560
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7,127	5,880	8,162	9,204	10,560
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	55.4	46.3	65	73.6	84.5
Dividends per Share
Special Dividends per Share